Radiation and Cancer Biology Group; Quantitative RedOx Sensing Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Radiation and Cancer Biology Group; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):260-271. doi: 10.1016/j.ijrobp.2021.04.001. Epub 2021 Jun 7.
Autophagy and cell-cycle checkpoints act in concert to confer cellular radioresistance. We investigated the functional interaction between radiation-induced autophagy and G2 checkpoint activation in highly radioresistant human pancreatic ductal adenocarcinoma (PDAC) cells.
Four human PDAC cell lines (MIA PaCa-2, KP-4, Panc-1, and SUIT-2) were analyzed. These cells were first irradiated using x-rays, and their cell cycle status, autophagy, and cell cycle checkpoint marker expression and ATP production levels were evaluated. Autophagic flux assays and siRNA knockdown were used to evaluate autophagy activity. Double thymidine block experiments were performed to synchronize the cells. Two inhibitors (MK-1775 and SCH 900776) were used to attenuate G2 checkpoint activation. Cell survival assays and animal experiments were performed to evaluate the radiosensitizing effects of the G2 checkpoint inhibitors.
Autophagy and G2/M accumulation were synchronously induced in human PDAC cells with an activated G2 checkpoint at 12 hours after x-ray irradiation of 6 Gy. Radiation-induced autophagy produced the ATP levels required for cell survival. Double thymidine block experiments revealed that no autophagy occurred in cells that were solely in G2 phase. MK-1775 or SCH 900776 exposure attenuated not only G2 checkpoint activation but also postirradiation autophagy, indicating the dependence of radiation-induced autophagy on an activated G2 checkpoint. The inhibitors demonstrated a higher radiosensitizing effect in the PDAC cells than the autophagy inhibitor chloroquine. MK-1775 in combination with x-rays significantly suppressed the tumor growth of MIA PaCa-2 xenografts compared with other treatment groups, including radiation or drug exposure alone, to enhance the radiosensitivity of PDAC cells in vivo.
Biological crosstalk exists between the G2 checkpoint activation and radiation-induced autophagy processes that are believed to independently contribute to the radioresistance of human PDAC cells. These findings have important implications for the development of future radiation therapy strategies for PDAC.
自噬和细胞周期检查点协同作用以赋予细胞放射抗性。我们研究了在高度耐辐射的人胰腺导管腺癌(PDAC)细胞中辐射诱导的自噬与 G2 检查点激活之间的功能相互作用。
分析了 4 个人 PDAC 细胞系(MIA PaCa-2、KP-4、Panc-1 和 SUIT-2)。首先用 X 射线照射这些细胞,评估它们的细胞周期状态、自噬、细胞周期检查点标志物表达和 ATP 产生水平。使用自噬通量测定和 siRNA 敲低来评估自噬活性。进行双胸苷阻断实验以同步细胞。使用两种抑制剂(MK-1775 和 SCH 900776)来减弱 G2 检查点激活。进行细胞存活实验和动物实验来评估 G2 检查点抑制剂的放射增敏作用。
在 X 射线照射 6 Gy 后 12 小时,具有激活的 G2 检查点的人 PDAC 细胞中同步诱导自噬和 G2/M 积累。辐射诱导的自噬产生了细胞存活所需的 ATP 水平。双胸苷阻断实验表明,仅处于 G2 期的细胞中没有自噬发生。MK-1775 或 SCH 900776 暴露不仅减弱了 G2 检查点激活,还减弱了辐射后自噬,表明辐射诱导的自噬依赖于激活的 G2 检查点。与自噬抑制剂氯喹相比,抑制剂在 PDAC 细胞中表现出更高的放射增敏作用。与其他治疗组(包括单独放疗或药物暴露)相比,MK-1775 联合 X 射线显著抑制 MIA PaCa-2 异种移植瘤的生长,从而增强了 PDAC 细胞在体内的放射敏感性。
G2 检查点激活和辐射诱导的自噬过程之间存在生物学相互作用,这两个过程都被认为独立地导致人 PDAC 细胞的放射抗性。这些发现对开发用于 PDAC 的未来放射治疗策略具有重要意义。